Related Experiment Videos
Spinocerebellar ataxia type 10: a disease caused by a large ATTCT repeat expansion
Tohru Matsuura1, Tetsuo Ashizawa
1Department of Neurology, Baylor College of Medicine and Veterans Affairs Medical Center, Houston, Texas 77030 USA.
Advances in Experimental Medicine and Biology
|March 4, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Neurochemical Endpoints to Inform Early-Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting.
Annals of clinical and translational neurology·2026
A Severity-Agnostic Atrophy Pattern in Spinocerebellar Ataxia Type 3: Volumetrics from ENIGMA-Ataxia.
Movement disorders : official journal of the Movement Disorder Society·2026
Factors associated with severe neurological sequelae of COVID-19: findings from the multicenter COVID-BRAIN imaging cohort.
Frontiers in human neuroscience·2026
Value of MRI Outcomes for Preventive and Early-Stage Trials in Spinocerebellar Ataxias 1 and 3.
Annals of clinical and translational neurology·2026
Nucleoskeletal Proteins in Early Embryogenesis.
Advances in experimental medicine and biology·2026
Nuclear Dynamics and Its Timing Regulation Revealed by Live-Cell Imaging.
Advances in experimental medicine and biology·2026
Histone Modifications in Mammalian Early Embryos.
Advances in experimental medicine and biology·2026
Oocyte Kinetochores at the Nexus of Meiotic Drive and Segregation Fidelity.
Advances in experimental medicine and biology·2026
Asymmetric Chromosome Establishment and Segregation During Germline Stem Cell Division.
Advances in experimental medicine and biology·2026
Non-random Sister Chromatid Segregation Mediated by Ribosomal DNA in Drosophila Male Germline Stem Cells.
Advances in experimental medicine and biology·2026
Short-term heart rate variability is preserved in Parkinson's disease under atomoxetine.
Brain communications·2026
Goreisan-mediated suppression of chemokine and cytokine production in astrocytes under AQP4-expressing conditions.
Frontiers in neuroscience·2026
Switching to Angiotensin Receptor-Neprilysin Inhibitor and Reduced Risk of New-Onset Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction: A Nationwide Propensity Score-Matched Study.
European heart journal. Cardiovascular pharmacotherapy·2026